Literature DB >> 28983189

On Estimation of Optimal Treatment Regimes For Maximizing t-Year Survival Probability.

Runchao Jiang1, Wenbin Lu1, Rui Song1, Marie Davidian1.   

Abstract

A treatment regime is a deterministic function that dictates personalized treatment based on patients' individual prognostic information. There is increasing interest in finding optimal treatment regimes, which determine treatment at one or more treatment decision points so as to maximize expected long-term clinical outcome, where larger outcomes are preferred. For chronic diseases such as cancer or HIV infection, survival time is often the outcome of interest, and the goal is to select treatment to maximize survival probability. We propose two nonparametric estimators for the survival function of patients following a given treatment regime involving one or more decisions, i.e., the so-called value. Based on data from a clinical or observational study, we estimate an optimal regime by maximizing these estimators for the value over a prespecified class of regimes. Because the value function is very jagged, we introduce kernel smoothing within the estimator to improve performance. Asymptotic properties of the proposed estimators of value functions are established under suitable regularity conditions, and simulations studies evaluate the finite-sample performance of the proposed regime estimators. The methods are illustrated by application to data from an AIDS clinical trial.

Entities:  

Keywords:  Inverse probability weighted estimation; Kaplan-Meier estimator; optimal treatment regime; personalized medicine; survival probability; value function

Year:  2016        PMID: 28983189      PMCID: PMC5624740          DOI: 10.1111/rssb.12201

Source DB:  PubMed          Journal:  J R Stat Soc Series B Stat Methodol        ISSN: 1369-7412            Impact factor:   4.488


  12 in total

1.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

2.  Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.

Authors:  Y Q Zhao; D Zeng; E B Laber; R Song; M Yuan; M R Kosorok
Journal:  Biometrika       Date:  2015-03-01       Impact factor: 2.445

3.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

4.  Optimal treatment regimes for survival endpoints using a locally-efficient doubly-robust estimator from a classification perspective.

Authors:  Xiaofei Bai; Anastasios A Tsiatis; Wenbin Lu; Rui Song
Journal:  Lifetime Data Anal       Date:  2016-08-01       Impact factor: 1.588

5.  EFFECTIVELY SELECTING A TARGET POPULATION FOR A FUTURE COMPARATIVE STUDY.

Authors:  Lihui Zhao; Lu Tian; Tianxi Cai; Brian Claggett; L J Wei
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

6.  Q-LEARNING WITH CENSORED DATA.

Authors:  Yair Goldberg; Michael R Kosorok
Journal:  Ann Stat       Date:  2012-02-01       Impact factor: 4.028

7.  Evaluating marker-guided treatment selection strategies.

Authors:  Roland A Matsouaka; Junlong Li; Tianxi Cai
Journal:  Biometrics       Date:  2014-04-29       Impact factor: 2.571

8.  A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

Authors:  S M Hammer; D A Katzenstein; M D Hughes; H Gundacker; R T Schooley; R H Haubrich; W K Henry; M M Lederman; J P Phair; M Niu; M S Hirsch; T C Merigan
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

9.  Estimating Optimal Treatment Regimes from a Classification Perspective.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Marie Davidian; Min Zhang; Eric Laber
Journal:  Stat       Date:  2012-01-01

10.  Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Biometrika       Date:  2013       Impact factor: 2.445

View more
  9 in total

1.  DOUBLY ROBUST ESTIMATION OF OPTIMAL TREATMENT REGIMES FOR SURVIVAL DATA-WITH APPLICATION TO AN HIV/AIDS STUDY.

Authors:  Runchao Jiang; Wenbin Lu; Rui Song; Michael G Hudgens; Sonia Naprvavnik
Journal:  Ann Appl Stat       Date:  2017-10-05       Impact factor: 2.083

2.  Identification of the optimal treatment regimen in the presence of missing covariates.

Authors:  Ying Huang; Xiao-Hua Zhou
Journal:  Stat Med       Date:  2019-11-27       Impact factor: 2.373

3.  ON ESTIMATION OF THE OPTIMAL TREATMENT REGIME WITH THE ADDITIVE HAZARDS MODEL.

Authors:  Suhyun Kang; Wenbin Lu; Jiajia Zhang
Journal:  Stat Sin       Date:  2018-07       Impact factor: 1.261

4.  Quantile-Optimal Treatment Regimes.

Authors:  Lan Wang; Yu Zhou; Rui Song; Ben Sherwood
Journal:  J Am Stat Assoc       Date:  2018-06-08       Impact factor: 5.033

5.  Effects of Proportional Hazard Assumption on Variable Selection Methods for Censored Data.

Authors:  Alvin Sheng; Sujit K Ghosh
Journal:  Stat Biopharm Res       Date:  2019-12-23       Impact factor: 1.452

6.  Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data.

Authors:  Rebecca Hager; Anastasios A Tsiatis; Marie Davidian
Journal:  Biometrics       Date:  2018-05-18       Impact factor: 2.571

7.  Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes.

Authors:  Zhengling Qi; Dacheng Liu; Haoda Fu; Yufeng Liu
Journal:  J Am Stat Assoc       Date:  2019-04-11       Impact factor: 5.033

8.  Multithreshold change plane model: Estimation theory and applications in subgroup identification.

Authors:  Jialiang Li; Yaguang Li; Baisuo Jin; Michael R Kosorok
Journal:  Stat Med       Date:  2021-04-11       Impact factor: 2.497

9.  On restricted optimal treatment regime estimation for competing risks data.

Authors:  Jie Zhou; Jiajia Zhang; Wenbin Lu; Xiaoming Li
Journal:  Biostatistics       Date:  2021-04-10       Impact factor: 5.899

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.